about
Typologies of prescription opioid use in a large sample of adults assessed for substance abuse treatmentData Sources Regarding the Nonmedical Use of Pharmaceutical Opioids in the United States.Evaluating the drug use "gateway" theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys.HIV risk behavior in opioid dependent adults seeking detoxification treatment: an exploratory comparison of heroin and oxycodone users.Probability and predictors of the cannabis gateway effect: a national studyPrescription opioid misuse and mental health among young injection drug users.Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997-2007.Initiation into prescription opioid misuse amongst young injection drug usersHepatitis C surveillance among youth and young adults in New York City, 2009-2013.Prevalence and experience of chronic pain in suburban drug injectors.Respondent-driven sampling to recruit young adult non-medical users of pharmaceutical opioids: problems and solutions.Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: a cross-sectional comparison and retrospective survival analysis.Misuse of prescription and illicit drugs among high-risk young adults in Los Angeles and New York.Problematic use of prescription-type opioids prior to heroin use among young heroin injectors.Understanding the etiology of prescription opioid abuse: implications for prevention and treatmentPrevalence of HIV infection and risk behaviors among younger and older injecting drug users in the United States, 2009Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population.Does the 'gateway' matter? Associations between the order of drug use initiation and the development of drug dependence in the National Comorbidity Study Replication.Use and Misuse of Opioids in Maine: Results From Pharmacists, the Prescription Monitoring, and the Diversion Alert Programs.Women who abuse prescription opioids: findings from the Addiction Severity Index-Multimedia Version Connect prescription opioid database.Simultaneous recruitment of drug users and men who have sex with men in the United States and Russia using respondent-driven sampling: sampling methods and implicationsGender and comorbidity among individuals with opioid use disorders in the NESARC study.Factors associated with being asked to initiate someone into injection drug useProblematizing 'drugs': A cultural assessment of recreational pharmaceutical use among young adults in the USAssociations between injection risk and community disadvantage among suburban injection drug users in southwestern Connecticut, USA.Toward primary prevention of extra-medical OxyContin® use among young peopleNational trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999-2009.An Examination of the Importance of Strain in the Cannabis Gateway Effect.US regional and demographic differences in prescription opioid and heroin-related overdose hospitalizations.Self-limiting non-medical pharmaceutical opioid use among young people in Sydney, Australia: An exploratory study.Prevention knowledge, risk behaviours and seroprevalence among nonurban injectors of southwest ConnecticutHepatitis C Cascade of Care Among Pregnant Women on Opioid Agonist Pharmacotherapy Attending a Comprehensive Prenatal Program.Next steps in research on injection initiation incidence and prevention.Shifting blame: Buprenorphine prescribers, addiction treatment, and prescription monitoring in middle-class America.Prescription opioids prior to injection drug use: Comparisons and public health implications.A qualitative comparison of parent and adolescent views regarding substance use.From oxycodone to heroin: two cases of transitioning opioid use in young Australians.The gateway hypothesis of substance abuse: an examination of its applicability in the Nigerian general population.Nonmedical prescription opioid use and illegal drug use: initiation trajectory and related risks among people who use illegal drugs in Vancouver, Canada.Patient perspectives of transitioning from prescription opioids to heroin and the role of route of administration.
P2860
Q28743202-4CA392F3-58CD-400F-B4A6-9B7302443B14Q30881147-0AE1D77B-5FC3-46B6-955D-2064725325E2Q33522825-8731F30A-E3CB-41CB-9BBA-15DC93306E94Q33999306-68E84637-EA8B-4A26-962F-4037B418C2A0Q34435738-E984F9CC-2CC5-4184-85BC-71A7F12E7C81Q34674284-C40E6F66-2935-4C25-93F4-7D853DD8A014Q34984833-E1AD438B-897C-4BCE-814E-E9E704941871Q35388380-B556A454-13A2-44D1-91FE-BEE5D18BB74BQ35543351-728E9619-7632-4C4C-8BB2-9BB1C73BA784Q35660924-45366FFE-806E-4BB6-8F26-4C11B96FCE7CQ35667147-06766031-546C-4C29-AFD7-B14084D2B806Q35683199-2F243680-997E-4D31-B096-3B710712FEC6Q36093977-146C43AD-6F9A-4F1D-AC2E-79BA05544A7AQ36505814-F12A748E-C5AE-428B-9684-8E80D4B32CC8Q36924019-386AA1C9-9DBE-4FF8-AFB1-BF40A48B0ABFQ37040594-D2012266-F7D9-4418-949C-8AD8E038F648Q37116421-3C5A09D5-6B88-4DFD-B2F7-324ECAA5151EQ37122068-A6E2C459-CE9D-42CC-9B54-F1762BB71F85Q37180212-46FDC1EF-59CD-42D7-AEE4-3A83D6DFF461Q37227555-4AB07A48-5A7A-4402-A41B-2F33C7E7E60CQ37249708-F2EEC528-F334-4230-BA8B-2EA817D19174Q37255520-F837BAD8-7C8D-49F3-A801-E9292A9D1C47Q37308020-023B160F-1860-4761-ADB8-26976429EFAAQ37466913-4DECB5F3-7279-45B9-BE25-CEFADC78B635Q37568363-0E5513BD-D0A0-4F68-A5D4-2FB9BC62ADC0Q37592351-33D4465E-DD48-4110-89E0-1D425577FDB0Q37604339-53B41207-A23F-4C20-B3EC-B9171F3EC10DQ38597564-1FD5726E-6AE4-4307-8CED-7FE3AA49411EQ38688434-16EA0C95-B56D-4AD2-8A0D-2E0A3E7DDBACQ38895082-BC0F5634-3D68-431D-9E54-86E4AF461DDAQ39855070-8871F653-8881-478E-B7AD-982163893483Q40126429-8FA4A09B-04C6-4823-9497-165C9BC294CBQ40296351-5000E139-D8F0-4C92-A264-29D9A9F2E292Q40395088-8DB229F2-6548-47EB-9409-C6361775C2A9Q40604048-05E9291E-A7B0-4D66-A2C9-3C1929499EBAQ43191790-B130CB28-B95F-41EA-A825-9926B733718CQ43523850-3935DBC5-87F9-4598-BF94-505E328D41F8Q46154716-55BDDEB3-0F01-4256-85C2-83F4407D74DCQ47729402-3B21D284-C8DB-44AE-96BE-C5C1A24EBFF2Q48148489-64DE968F-CD5C-4062-98C5-CDCBCDCF71C3
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Illicit use of opioids: is OxyContin a "gateway drug"?
@en
Illicit use of opioids: is OxyContin a "gateway drug"?
@nl
type
label
Illicit use of opioids: is OxyContin a "gateway drug"?
@en
Illicit use of opioids: is OxyContin a "gateway drug"?
@nl
prefLabel
Illicit use of opioids: is OxyContin a "gateway drug"?
@en
Illicit use of opioids: is OxyContin a "gateway drug"?
@nl
P2093
P1476
Illicit use of opioids: is OxyContin a "gateway drug"?
@en
P2093
Alison Phinney Harvey
Anthony Givens
Kevin Irwin
Lauretta E Grau
Mark L Kinzly
Robert Heimer
P304
P356
10.1080/10550490701375293
P577
2007-05-01T00:00:00Z